← All companies

CRL

Charles River Laboratories International, Inc.

CRL NYSE Services-Commercial Physical & Biological Research EDGAR ↗

$256.27

+22.14 +9.46%

Key statistics

from XBRL data in SEC filings

Market cap

$12.2B

Revenue (TTM)

$4.00B

Net income (TTM)

-$238M

EPS (TTM)

$-4.80

P/E ratio

—

Dividend yield

—

Free cash flow

$522M

Cash

$192M

Total assets

$7.53B

Gross margin

26.8%

52-week range

$144.26 – $266.00

Recent SEC filings

40 most recent

Annual, quarterly & current reports

10-Q Quarter ended 2026-06-27 Aug 5, 2026 8-K Results of operations (earnings release) Aug 5, 2026 8-K Director or officer change; Shareholder vote results May 11, 2026 10-Q Quarter ended 2026-03-28 May 7, 2026 8-K Results of operations (earnings release) May 7, 2026 8-K Regulation FD disclosure Feb 25, 2026 8-K Director or officer change Feb 18, 2026 10-K Fiscal year ended 2025-12-27 Feb 18, 2026 8-K Results of operations (earnings release) Feb 18, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Jan 13, 2026 8-K Director or officer change Jan 9, 2026 8-K Regulation FD disclosure Dec 3, 2025 8-K Other events Nov 17, 2025 10-Q Quarter ended 2025-09-27 Nov 5, 2025 8-K Results of operations (earnings release) Nov 5, 2025 8-K/A Director or officer change Sep 19, 2025 8-K Director or officer change; Regulation FD disclosure Sep 16, 2025 10-Q Quarter ended 2025-06-28 Aug 6, 2025 8-K Results of operations (earnings release) Aug 6, 2025 8-K Director or officer change; Shareholder vote results May 23, 2025 10-Q Quarter ended 2025-03-29 May 7, 2025 8-K Entered a material agreement; Director or officer change; Regulation FD disclosure May 7, 2025 8-K Results of operations (earnings release) May 7, 2025 8-K Other events Feb 21, 2025 10-K Fiscal year ended 2024-12-28 Feb 19, 2025 8-K Results of operations (earnings release) Feb 19, 2025 8-K Regulation FD disclosure Jan 14, 2025 8-K Took on a direct financial obligation Dec 13, 2024 10-Q Quarter ended 2024-09-28 Nov 6, 2024 8-K Results of operations (earnings release) Nov 6, 2024 10-Q Quarter ended 2024-06-29 Aug 7, 2024 8-K Results of operations (earnings release) Aug 7, 2024 8-K Shareholder vote results May 10, 2024 10-Q Quarter ended 2024-03-30 May 9, 2024 8-K Results of operations (earnings release) May 9, 2024 10-K Fiscal year ended 2023-12-30 Feb 14, 2024 8-K Results of operations (earnings release) Feb 14, 2024 8-K Director or officer change Jan 24, 2024 8-K Director or officer change Jan 16, 2024 8-K Other events Nov 15, 2023